Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:186-191
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azevedo, E. R.
Right arrow Articles by Parker, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azevedo, E. R.
Right arrow Articles by Parker, J. D.

Cardiac and systemic sympathetic activity in response to clonidine in human heart failure

Eduardo R. Azevedo, MDa, Gary E. Newton, MDa and John D. Parker, MD, FACCa

a Division of Cardiology, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada



View larger version (15K):

[in a new window]
 
Figure 1 Hemodynamic responses to 50 and 100 µg of clonidine. FAmean = mean femoral artery pressure; LVEDP = left ventricular end-diastolic pressure; LV+dP/dt = rate of rise in left ventricular peak positive pressure; TL = rate of isovolumic relaxation measured by the method of Weiss (18). *p < 0.05 versus control. {dagger}p < 0.01 versus control. Data are expressed as the mean value ± SEM.

 


View larger version (9K):

[in a new window]
 
Figure 2 Cardiac norepinephrine spillover (CANESP) and total body norepinephrine spillover (TBNESP) at control values and in response to 50 and 100 µg of clonidine. *p < 0.05 versus control. {dagger}p < 0.01 versus control. Data are expressed as the mean value ± SEM.

 


View larger version (15K):

[in a new window]
 
Figure 3 Arterial (open bars) and coronary sinus (solid bars) plasma norepinephrine at control values and in response to 50 and 100 µg of clonidine. There is a significant reduction in the transcardiac gradient of plasma norepinephrine in response to 100 µg of clonidine. This results from a significantly greater decrease in the coronary sinus plasma norepinephrine level as compared with the arterial plasma norepinephrine level. *p < 0.05 versus control. {dagger}p < 0.01 versus control. {ddagger}p < 0.05 for comparison between the norepinephrine transcardiac gradient (coronary sinus – arterial) with 100 µg of clonidine and control level. Data are expressed as the mean value ± SEM.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement